1. Home
  2. HIMX vs HRMY Comparison

HIMX vs HRMY Comparison

Compare HIMX & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Himax Technologies Inc.

HIMX

Himax Technologies Inc.

HOLD

Current Price

$13.50

Market Cap

2.5B

Sector

Technology

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

N/A

Current Price

$42.86

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HIMX
HRMY
Founded
2001
2017
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.2B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
HIMX
HRMY
Price
$13.50
$42.86
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$44.11
AVG Volume (30 Days)
1.2M
679.4K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
3.23%
N/A
EPS Growth
N/A
7.97
EPS
N/A
1.84
Revenue
N/A
$868,453,000.00
Revenue This Year
$14.94
$19.75
Revenue Next Year
$7.79
$12.88
P/E Ratio
$14.99
$22.42
Revenue Growth
N/A
21.51
52 Week Low
$6.85
$25.52
52 Week High
$25.09
$41.49

Technical Indicators

Market Signals
Indicator
HIMX
HRMY
Relative Strength Index (RSI) 45.63 70.60
Support Level $13.02 $34.87
Resistance Level $15.91 N/A
Average True Range (ATR) 0.49 1.19
MACD -0.05 0.22
Stochastic Oscillator 14.20 99.03

Price Performance

Historical Comparison
HIMX
HRMY

About HIMX Himax Technologies Inc.

Himax Technologies Inc is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The majority of the firm's revenue is derived from the Driver Integrated Circuit segment. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, virtual reality (VR) devices, and many other consumer electronics devices. It also designs and provides controllers for touch sensor displays, in-cell Touch and Display Driver Integration single-chip solutions, LED driver ICs, power management ICs, and scaler products for monitors and projectors. Geographically, it generates the majority of its revenue from China.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: